Page 72 - MEMOCiberesp014-ENG
P. 72
RESEARCH GROUPS
Ocular Surface Inflammation
& Advanced Therapies Groups
Programme: Biomaterials and Advanced Therapies
Lead Researcher: Calonge Cano, Margarita Group Members
STAFF MEMBERS: Fernández Martínez, Itziar | Nieto Miguel, Teresa | Rey Fernández, Rosa Esther ASSOCIATED MEMBERS: Diebold Luque, Yolanda | Enríquez de Salamanca Aladro, Amalia | González
García, María Jesús | Herreras Cantalapiedra, José María | Iglesias Muñoz, Francisco Javier
CONTRIBUTORS: Corell Almuzara, Alfredo | Galindo de la Rosa, Sara | López Paniagua, Marina | Reinoso Tapia, Roberto | Soriano Romani, Laura
Main lines of research
VERTICAL RESEARCH LINES:
• Advances therapies . Target diseases: Corneal blindness caused by limbal stem cell deficiency . Field of research: Cell therapy, Tissue engineering, Clinical Trials
• Inflammation . Target diseases: Dry Eye Syndrome, Allergy, Other immune-based diseases . Field of research: In vitro models, Biomarkers and new therapies, Environmental stress, Contact lenses .
• Nanomedicine . Target diseases: Dry Eye Syndrome, Allergy, Other immune-based diseases . Field of research: Drug delivery systems, Gene therapy, Gene silencing .
HORIZONTAL RESEARCH LINES:
• Physiology and Immunology . Field of research: Characterization of eye associated lymphoid tissue in health and disease .
• Clinical trials . Target disease: Ocular surface inflammation, Limbal stem cell deficiency, Intraocular inflammation (Uveítis), Contact lens-associated pathologies . Field of research: Cell therapy, Drug the- rapy, Contact lenses .
72
CIBER-BBN » Annual report 2014
